ArticleBlood advances2021

Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma.

Arnold Bolomsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.